AI assistant
Sending…
ORAGENICS INC — Director's Dealing 2020
May 4, 2020
35380_dirs_2020-05-04_588bf33e-df23-458b-890a-f33df60d0ae3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2020-05-01
Reporting Person: Murphy Kimberly M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-01 | Non-Employee Director Option (Right to Buy) | $0.4327 | A | 138664 | Acquired | 2030-05-01 | Common Stock (138664) | Direct |
Footnotes
F1: Represents an initial equity award upon appointment to the Company's board of directors of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vests immediately.
More from ORAGENICS INC
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Jan 22
Regulatory Filings
2026
Jan 22